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ABSTRACT 
The Institute of Medicine’s (IOM) publication To Err is Human identified medical and 
medication errors as a significant threat to public welfare and public health. In response to the 
publication the Institute for Healthcare Improvement (IHI) has created the “5,000,000 lives” 
campaign to reduce adverse outcomes due to error. Simultaneously, the IHI has promoted it’s 
Triple Aim Campaign which compels health care organizations to increase the health of 
populations while also minimizing patient costs and enhancing the patient experience. The 
UPMC Presbyterian Pharmacy department is redeploying its pharmacy resources in an attempt to 
better contribute to the principles of the Triple Aim Campaign and improve patient safety by 
enhancing its technical efficiency, improving operational services, and optimizing its automation 
to improve medication safety. 
The pharmacy department created service line groups that treat specific patient 
populations such as cardiology and neurology. These groups consist of a central pharmacist, 
unit-based pharmacist, and service line technician. This intervention was created to address the 
problem of medication delays and the lack of standardization and accountability for the provision 
of operational and clinical pharmacy services. Objective measures of performance include 
reported medication delays, missing medications, number of discharge prescriptions, and percent 
of total medications discharges from the automated dispensing cabinets and from the RobotRx 
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machine.  Comparison of pre-model to post-model pharmacy services showed that medication 
delays and missing medications decreased by 49% and 85%, respectively.  
The pharmacy department service line model has taken measures to improve patient 
health by minimizing medication delays and missing medications within UPMC Presbyterian 
hospital. This was accomplished by stream-lining services and improving the department’s 
technical efficiency and patient safety surrogates measures.  
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HEALTHCARE ENVIRONMENT 
 
Healthcare spending reached $2.9 trillion dollars or $9,255 per person, in 2013; 
accounting for 17.4% of the nation’s gross domestic product (GDP).1 This figure is more than 
two-and-a-half times higher than the average of other developed nations. Hospital services alone 
accounted for $936.9 billion of those GDP dollars, a growth of 4.5% from 2012.1 Despite 
spending seventeen cents of every dollar on health care, the United States still have fewer 
physicians and hospital beds per person compared to developed nations, and poorer average 
outcomes than the Organization for Economic Co-operation Development (OECD) nations in 
life expectancy and infant mortality.2,3  The Common Wealth Fund recently ranked the United 
States health care system last of eleven nations in quality measures related to access, equity, 
quality, efficiency, and healthy lives.4 The country has been osolating around this current state 
for well over a decade despite legislative efforts to slow inflating healthcare cost by creating 
incentives to improve quality while decreasing quantity.  
Legislators have attempted to control health care costs with the passage of laws that 
created the diagnosis-related-group (DRG), bundled payments, and value-based purchasing, all 
of which have been an attempt to decrease total reimbursement dollars for health care services 
billed to the Centers for Medicare and Medicaid Services (CMS). This reimbursement climate 
has resulted in health care insurance entities and providers to consolidate, streamline, and find 
efficiency in every aspect of health care operational service models. 5 High level health care 
administrators are asking front-line managers to provide cost-savings initiatives (CSI’s) to trim 
excessive waste from each individual department, preferably while providing more consistent 
and better quality care. 
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Simultaneously, there is a second trend within contemporary health care in the United 
States that is focused on patient-centered care, patient safety, and a universal desire to diminish 
and potentially abolish medical errors. This issue was most famously noted in the landmark 
publication, To Err is Human: Building a Safer Health System, published in 1999 by the Institute 
of Medicine (IOM).6 This was one of the first patient safety publications to highlight the sheer 
volume of medication and procedural errors that happen in United States hospitals. The Institute 
for Healthcare Improvement’s (IHI) reaction to the IOM publication was to create initiatives 
such as the 5,000,000 Lives Campaign to directly reduce adverse outcomes in patients due to 
error.7 The campaigns attempted to mitigate these errors by partnering with health care 
institutions to support the following efforts: 
• create and deploy rapid response teams at the first signs of significant clinical decline 
• deliver reliable, evidence-based care for acute myocardial infarction to prevent death 
• prevent adverse drug events (ADEs) by utilizing a variety of medication safety tools 
including medication reconciliation 
• prevent central line infections  
• prevent surgical site infections 
• prevent ventilator-associated pneumonia.7  
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The IHI has also compelled health care organizations to consider and pursue solutions 
that align with it’s Triple Aim Campaign designed to optimize health system performance. The 
Triple Aim pursues three goals: 
1. Improve the patient experience of care (including quality and satisfaction) 
2. Improve the health of populations  
3. Reduce the per capita cost of health care.8  
The IHI Triple Aim is largely a call to improve health care “efficiency.” Efficiency is a 
term widely used by economists to describe the best use of resources in production.9 A health 
care organization that does not fully maximize the productive potential of its resources is in a 
state of technical and/or allocative inefficiency.10 Technical inefficiency is a production state that 
does not achieve a maximum output from the mix of input combinations that are within a 
process, and therefore not producing at maximum capacity.10 Allocative inefficiency is a state of 
production that does not minimize cost with given input prices or maximize revenues with given 
output prices.9   
This paper will analyze and discuss a pharmacy department operational model 
modification designed to address the triple aim challenge. Through process redesign, the 
pharmacy department will seek to achieve technical efficiency while achieving greater patient 
safety by reallocating pharmacist medication order verification responsibilities, optimizing 
medication dispensing automation, and redeploying pharmacy technicians into a customer 
service role rather than a purely delivery role. This study will assess pharmacy order volume per 
unit, order volume per time, and order volume per verification queue, in order to best inform 
service line redistribution. For simplicity, each model will be referred to as “Pre-model” and 
“Post-model,” respectively. A pre/post comparison will be conducted in order to evaluate 
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automation efficiency and surrogate markers for medication delays. Automation efficiency will 
be assessed by comparing automated dispensing machine (ADM) stockouts and percent of 
medications dispensed by the RobotRx machine. Technician workflow efficiency will be 
assessed by comparing missing/delayed medications reported by nursing. This paper will also 
discuss the potential positive impact on patient safety and consistency of pharmacy services. 
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UPMC PRESBYTERIAN HOSPITAL AND PHARMACY SERVICES 
 
UPMC Presbyterian is the large academic medical center that acts as the flagship hospital 
for the UPMC Hospital System. It is a designated level 1 trauma center and renowned center for 
excellence in abdominal transplant, cardiothoracic transplant, cardiology, critical care medicine, 
and neurosurgery. It consists of two patient care towers UPMC Presbyterian (PUH) and UPMC 
Montefiore (MUH) which house approximately 700 patient beds, combined, and both towers are 
serviced by a single central pharmacy located within PUH tower. 
Pharmacy Services  
The pharmacy department at PUH is responsible for the procurement, storage, 
compounding, labeling, and delivering of medications to all patient units and departments in a 
safe and timely manner. The pharmacy provides comprehensive clinical pharmacy services to 
those units and departments with most need (i.e. intensive care units, high acuity patients, 
sophisticated medication regimens). The clinical pharmacy services offered by the pharmacy 
department are driven by unit-based pharmacists and University of Pittsburgh School of 
Pharmacy faculty members that provide cognitive services such as medication recommendations, 
drug-disease state monitoring, and medical/pharmacy resident education. All pharmacists within 
the department are available to answer drug information questions regarding dose range 
verification, drug-laboratory evaluation, therapeutic medication interchanges, and medication 
route of administration recommendations to ensure the safest and most stream-lined drug 
administration regimen.  
6 
 
PHARMACY MEDICATION VERIFICATION AND DISTRUBUTION PROCESS 
 
Figure 1: Medication order and process flow chart 
 
ADM=Automated dispensing machine 
 
Figure 1 is a schematic of the medication ordering, verification, processing, and 
delivering workflow at UPMC Presbyterian. The process begins with an electronic order that is 
entered into a computer system that links a drug regimen request to a specific patient. This 
electronic order is called a computerized physician order entry (CPOE) (1A). That order is then 
electronically routed to a pharmacist who assesses the appropriateness of the order (4). Once the 
order is verified by the pharmacist an electronic signal is sent to pharmacy automation system to 
be process the requested medication by one of three pathways; by manual pick by a pharmacy 
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technician (5B), by pick and verification by the RobotRx® machine (5A), or by dispensing from 
an automated dispensing machine (ADM) strategically located within a patient unit or hospital 
department (5C). Note that all medications manually picked by a technician and verified by a 
pharmacist (6) or dispensed by the RobotRx® machine must be delivered by a pharmacy 
technician to the medication central drop area located within each hospital units (7-8). If the 
medication is located within the ADM the automation system will activate the medication within 
the patient’s medication profile to be dispensed from that ADM located on the unit (5C).  
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SAFETY AND EFFICIENCY CHALLENGES OF THE PRE-MODEL 
 
The pre-model suffers from operational challenges that stem from inequitable order 
verification volume and non-optimized automation systems resulting in poor workflow, duplicate 
order processing, excessive medication delay, and therefore potential patient safety risks. The 
problem list, potential sources and causes of problems, interventions, and possible safety 
correlations are described in Table 1.  
The first identifiable problem is medication delays. There are a variety of different 
scenarios that may result in a medication delay, the first of which is an ADM stockout. The 
ADM carries certain medications that are restocked every 24 hours. Each medication within the 
ADM is programmed with a maximum stock amount (MAX) and a unit amount that triggers that 
a notification that a restock is needed for that medication during the next refill process (PAR). 
Poorly programmed medication maxes and pars can result in either an over utilization of 
valuable ADM medication space, or an under stocking of medication which can result in the 
ADM medication inventory reaching zero. When this happens nurses are unable to access the 
needed medication which results in a missing dose request and/or a phone call to pharmacy. The 
central pharmacy is less prepared to process medications that should be dispensed through the 
ADM because in order to do so, the pharmacist must bypass the usual automation chain of events 
to dispense the medication from the central pharmacy. This results in duplication of work for 
both pharmacists and technicians, potential duplication of medications dispensed, medication 
delays, and a greater chance for error, jeopardizing the safety of the patient.   
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Medication delays may also be the product of practitioners ordering and requesting 
medications urgently, or STAT, when those medications are not truly appropriate for expedition 
of the typical workflow. The pharmacy is able to expedite STAT medications through one of two 
processes: 1. sending the medication to the unit through a pneumatic tube system to ensure rapid 
delivery; 2. sending a technician to hand-deliver the medication to the unit because the 
medication is too molecularly fragile to send through the pneumatic tube system. An overload of 
STAT medication requests creates a bottleneck for the pharmacy’s capacity to tube medications 
as well as STAT-run them with a technician resource. This may result in medications that truly 
are STAT, potentially being delayed because of STAT process flow saturation. An excessive 
amount of STAT medication requests also sets an unrealistic expectation for nurses and 
physicians, resulting in a perceived medication delay rather than a true delay. These perceived 
delays can result in duplicate dose requests and pharmacy phone calls, all of which disrupt 
normal pharmacy workflow and therefore delays the entire process chain. The overload of STAT 
medication requests may be the result of a lack of clinical understanding by the ordering 
practitioner and the verifying pharmacist and/or a CPOE design flaw that prompts physicians to 
choose STAT more frequently than necessary.  
The second problem identified is inefficient and inconsistent deployment of pharmacist 
services. The first possible cause of inefficiency is the lack of standardization in the types of 
medication orders. This contributes to the lack of specialized services that are provided by 
central pharmacists because they are expected to effectively answer questions about all disease-
states and all drugs available rather than a sub-specialty of the like. The lack of standardization 
also results in a lack of accountability for pharmacy cognitive and distributive services because 
there are not defined roles within the structure. A second possible cause of inefficient service is 
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an inequitable volume of medication orders routed to each pharmacist through the pharmacy 
verification queue infrastructure. This order volume inequity results in some pharmacists being 
pushed beyond there verification capacity, creating a bottleneck in order verification through-
put; while other pharmacists are not at full capacity.  
Another issue that stems from the inconsistent and strained central operations is that it 
negatively affects the clinical capacity of our unit-based pharmacists. In certain scenarios the 
capacity of the central pharmacists is maximized but still in need of assistance. In order to fulfill 
the order verification need, clinical pharmacists may be removed from their clinical role in order 
to assist in a central pharmacist role to ensure that medications are processed in a timely manner. 
This results in unpredictable and unreliable clinical services which removes a valuable layer to 
pharmacy patient care.   
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METHODS 
 
The first step was to assess average order volume per unit and average order volume over 
time in order to inform the new structure of verification queues. This was completed by assessing 
reports of order volume for all units for a one month period and averaging the amount of orders 
processed per unit per single hour of a day.  It should be noted that only orders designated as 
“new” were included in the order volume assessment. The researchers assume that “discontinue,” 
“cancel,” or “modify” orders are less time intensive and therefore were excluded.  We used this 
data to verify the number of orders per pharmacy queue in the pre-model state and then used this 
pre-model data to redistribute electronic medication order flow in a more equitable manner. Once 
the verification queues were redistributed in an equitable manner (post-model) the second step 
was to access surrogate data for efficiency and safety for both the pre and post-model for 
comparison. Surrogate data for medication safety and efficiency were ADM number of 
stockouts, reported missing doses, and percent of RobotRx dispenses. This data was compiled by 
querying the pharmacy automation system using its reporting functionality. The following data 
surrogates to compare the safety and efficiency of the pre-model versus post-model.  
• Average ADM stock-out per 24 hours 
• Total number of missing doses over a one week period 
• Percent of total doses dispensed from the RobotRx machine over a one week period 
• Percent of total doses dispensed from ADM machines over one week period. 
These particular measures are surrogates for both safety and efficiency because ADM 
stockouts and missing medications may potentially cause a delay in patient care which is a 
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medication error. The percent of RobotRx dispenses is also a marker for safety and efficiency 
because it has a near 100% accuracy when picking medications and it does not require manual 
manipulation for picking and checking by a pharmacist and technician. Percent of medications 
dispensed by the RobotRx as well as the ADM will be analyzed using chi square with Yates 
correction.  
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Table 1: Pharmacy problem list, possible causes, and system changes pursued 
Problem List Source of Problem Proposed Cause System Change Possible Benefit 
Medication Delays 
ADM stockouts* 
Incorrect medication 
Max and Par 
Modify inventory 
pars to last 24 hours 
consistently 
Decrease medication 
delays 
Incorrect medication 
types within the 
ADM 
Remove 
medications that are 
predictability 
scheduled and non-
emergent 
Decrease missing 
medications and delay 
STAT medication 
order overload 
Lack of clinical 
understanding of 
medication by 
requestor 
Increased education 
by cognitive 
services 
Decrease medication 
delay of true STAT 
medication 
Lack of clinical 
understanding of 
medication by 
pharmacist 
Increased service-
line education to 
specialized central 
pharmacist 
Increase quality of 
order scrutiny by 
central pharmacist 
High percentage of 
manual pick 
medications 
Lack of robotics 
optimization 
Modify RobotRx 
contents to increase 
automation 
utilization 
Improved medication 
dispensing accuracy 
Medication 
administrator cannot 
find medication* 
Lack of 
understanding of 
where medications 
are stored 
Provide education 
through unit-based 
technician 
Fewer reported 
missing doses 
Inefficient 
deployment of 
pharmacy services 
Lack of 
standardization of 
order verification 
queues for 
pharmacists* 
Various patient 
populations within 
each verification 
queue 
Redistribute 
pharmacist order 
verification queues 
to service particular 
service lines and to 
align equity of order 
volume 
Increase quality of 
order scrutiny by 
central pharmacist; 
Consistent 
communication; 
increased continuity 
of pharmacy care 
Inequitable order 
verification volume 
per pharmacist 
Lack of specialized 
central pharmacy 
services 
Inconsistent 
pharmacist 
scheduling practices 
Schedule a 
pharmacist to a 
service line 
consistently 
Lack of 
accountability for 
pharmacists 
distributive functions 
Inconsistent 
pharmacist 
scheduling practices 
 
Schedule a 
pharmacist to a 
service line 
consistently 
Performance may be 
tracked and critiqued 
for quality 
improvement 
Lack of 
accountability for 
pharmacists 
providing cognitive 
services 
 
Lack of 
standardization of 
cognitive services 
expectations 
Provide pharmacist 
development to 
create disease state 
experts 
Increase quality of 
order scrutiny by 
central pharmacist 
Significant 
time is spent 
providing distributive 
service recovery 
Provide technician 
support to service 
recovery 
Service recovery 
consistent and tracked 
for each service line 
* = Associated with data located in Table 4 
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RESULTS 
 
Order Verification Volume – Medication Delay 
Figure 2 shows the average number of new orders to verify per hour of the day averaged 
over a one month period. The 9:00 AM order verification peak is not surprising because this is 
the customary time for most patient care teams to begin rounding on intensive care unit patients. 
These orders are often entered in real-time during rounding, leading to the high order volume 
between the hours of 9:00 AM to 1:00 PM. 
Table 2 features the pre-model pharmacist order verification queues, their corresponding 
number of patient care units, and average order volume. The average order volume per 
pharmacist queue is 467 with a range of 279. Using the same order volume data, taking into 
account the type of disease states located within each unit, each pharmacy verification queue was 
reconstructed to create more equitable order volume while providing patient specific care. Table 
3 features the new pharmacist order verification queues after redistribution. The average order 
volume per queue is 443 with a range of only 111; a much lower variability. It should be noted 
that “M” queue in the pre-model and “Ancillary” queue in the post-model were excluded from 
the calculation because the pharmacists in these responsibilities have administrative duties and 
therefore are purposefully designed to have a smaller order volume.
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Figure 2: Average new order verification volume over 24 hours 
Table 2: Pre-model pharmacist order verification queue structure
 
* = Not included: This pharmacist services administrative functions; therefore we lighten queue 
volume 
 
Table 3: Reorganization of pharmacy queues – post-model
  
* = Not included: This pharmacist services administrative functions; therefore we lighten queue 
volume 
Unit Count Order Volume Order volume Average 
per queue
Variance Range
L 10 617 150
M 7 236* NA
N 6 384 -83
O 7 437 -30
P 7 371 -96
H 6 338 -129
I 6 538 71
J 9 584 117
467 279
Unit Count Order Volume
Order volume Average 
per queue Variance Range
TRAUMA 6 384 -60
NEUROLOGY 6 402 -42
CARDIOLOGY 6 465 22
ANCILLARY 
DEPARTMENTS
5 286.4* NA
ABDOMINAL 
TRANSPLANT
6 494 51
CT TRANSPLANT 5 426 -17
MEDICINE 9 468 25
MED SURG 9 464 21
443 111
16 
The Pharmacy Post-Model 
The central pharmacist is paired to a unit-based pharmacist and unit-based delivery 
technician to create a pharmacy disease-state service line that supports both clinical and 
distributive functions. The pharmacy service line will triage workflow in the following manner: 
• Central service line pharmacist
o receives all medication orders electronically via CPOE
o received phone calls from other providers regarding cognitive medication
questions
• Unit-based service line pharmacist
o receives clinical consult requests for drug-disease state management that are
relayed by the central service-line pharmacist by telephone
o provides rounding services with the medical team from 8:30A – 11:00A
o provide education to physicians and nurses regarding operational
• Unit-based service line technician
o delivery of medication
o service recovery by locating missing doses and triaging STAT medications
o provide education to physicians and nurses about medication locations
o receives calls for technical service recovery such as missing doses
Pharmacy Order Verification / Phone Queues 
Table 5, located in the appendix, features the distribution of all of the pharmacy order 
verification queues for the daylight shift central pharmacists. Each queue is labelled with a 
generic letter which is changed in the post-model to be associated to a particular disease state. 
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The daylight post-model pharmacist order verification structure consists of eight queues 
total:  
1. Trauma – features multiple trauma floors, Neuro trauma overflow, a neurovascular step 
down unit 
2. Neurology – features multiple neuro floors, neurovascular step down, neurovascular 
intensive care units, and one trauma floor.  
3. Cardiology – features multiple cardiac patient floors, the cardiac intensive care unit, the 
cardiothoracic intensive care unit, and cardiac pavilion. 
4. Abdominal Transplant – features solid organ transplant floors, transplant intensive care 
units, general intensive care unit overflow, and one medicine floor 
5. Cardiothoracic Transplant – features cardiothoracic transplant floors, lung transplant 
floors, and one medicine floor 
6. Ancillary – features the post-anesthesia care unit, dialysis unit, medical procedural unit, 
the emergency department and certain patient overflow areas. Note that this queue has a 
lower order volume because this person has administrative responsibility as well as order 
verification responsibility.  
7. Medicine – features multiple medicine floors, the medical intensive care unit, as well and 
the ear, nose, and throat patient units.  
8. Med Surg – features the surgical intensive care unit, orthopedics, rehabilitation unit, head 
and neck/gastrointestinal oncology, and nursing home units.  
Table 6 located in the appendix features daylight post-model pharmacist order verification 
structure including units, their descriptions, and order volume. 
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The UPMC Presbyterian pharmacy department provides twenty four hour per day 
service, three hundred and sixty five days a year, therefore the model must be collapsible 
because staffing allocations are decreased during evenings, nights, holidays, or call-off scenarios.  
The collapsed pharmacy order verification queues for both evening and nights are located within 
the appendix under tables 7 and 8, respectively. In order to ensure that every unit is covered 
during the evening shift the following order verification / phone queue changes were made from 
the day shift to the evening shift: 
1. Abdominal transplant and cardiothoracic transplant were collapsed into a single queue 
entitled transplant queue 
2. The Ancillary queue units are absorbed throughout all of the queues in an equitable 
manner 
3. The medicine queue absorbed one extra unit from the transplant queue in order to ensure 
equitable verification volume and remains entitled medicine 
The pharmacy verification responsibilities collapse again from the evening shift into the 
night shift. The following order verification/phone queue changes were made from evening shift 
to night shift.  
1. The daylight shift trauma, neuro, and cardio queues were merged  
2. The daylight ancillary and transplant queues were merged.  
3. The daylight medicine and med surg queues were merged  
Pre/Post Surrogate Marker Data Comparing Efficiency and Safety 
Table 4 features the pre and post-model safety and efficacy data. Reported medications 
delays decreased from 39 to 20 for a total decrease of 49%. Technicians were also capable of 
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decreasing reported missing from 45 to 8, an 85% decrease, by located the medications for 
nurses on the unit. The percent of medications dispensed from the RobotRx and ADM were 
analyzed using a chi square test with Yate’s correction to assess the statistical significance. 
RobotRx dispenses increased by 26% (P<0.0001) and medications dispensed from ADMs 
decreased by 28% (P<0.0001). The optimization of the automation resulted in a significant 
increase in medications that are dispensed by the RobotRx and a significant decrease in 
medications that are dispensed from the ADM. 
Table 4: Process measures pre and post model change 
Problem List Measurement Pre 
Model  
Post 
Model 
Percent 
Change 
(%) 
X2 with 
Yates 
correction 
Proposed 
Safety 
Correlation 
Medication 
Delays 
Average ADM 
stockouts per 
24 hours 
39 20 49% 
decrease 
 Fewer 
scenarios 
where 
medications 
are 
unavailable 
to nurses and 
physicians 
 
Missing 
Medications 
Reported 
missing 
medications 
45 7 85% 
decrease 
 
 
Inefficient 
automated 
medication 
distribution 
Percent of 
medications 
dispensed from 
the RobotRx 
37% 50% 26% 
increase 
P< 0.0001 Greater 
medication 
dispensing 
accuracy and 
efficiency 
Percent of 
medications 
dispensed from 
ADM 
39% 11% 28% 
decrease 
P< 0.0001 Greater 
utilization of 
ADM for 
PRN and 
STAT 
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DISCUSSION 
 
Efficacy and Safety 
The safety benefits of the RobotRx  has been documented in multiple different case 
studies, and has been reported to have a 99.9% medication filling accuracy.12-14 The RobotRx has 
also been shown to decrease technician labor by 72%, pharmacist checking time by 90%, and 
decrease missing medications by 92%.12-15 ADMs has been recognized by both the Institute for 
Safe Medication Practices (ISMP) and American Society of Health-System Pharmacists (ASHP) 
as a benefit to patient safety when utilized appropriately.16-19 The UPMC Presbyterian pharmacy 
department has systematically evaluated its automation in order to optimize the safety and 
efficiency of medication dispensing. Interventions made to optimize the RobotRx and the ADMs 
have resulted a 26%  increase in the utilization of the RobotRx machine for dispensing doses 
(P<0.0001) and a 28% decrease in utilization of the ADM  (P<0.0001). This means that there 
was a significantly greater utilization of the RobotRx for dispensing in the post-model compared 
to pre-model. This likely contributed to the decrease in utilization of the ADM in the post-model 
versus the pre-model. The post-model stock out rate also decreased by 49% which may be a 
result of the decreased variety of medications located within the optimized ADM or a more 
appropriate max and par setting to ensure that the unit never runs out of a needed medication.  
There are process flow benefits to the use of the RobotRx and the ADM located within 
the units. Medications that proceed through the RobotRx are robotically picked and verified 
which significantly decreased the chances of a medication picking error by a pharmacy 
technician or a pharmacy verification error by a pharmacist. It also provides efficiency because 
medications dispensed by the Robot do not need to be handled by those two human resources 
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(the technician and the pharmacist) prior to delivery. The ADM machine features a variety of 
medications that may be accessed instantly when verified for a particular patient within the unit. 
This provides the nurse with instant access to the medication rather than having to wait for the 
medication to be delivered from the central pharmacy. Note that this delivery method is 
particularly beneficial for medications that are needed as soon as possible or on an as needed 
basis, or an unpredictable manner. 
The pharmacist order verification queues were also redistributed to provide a more 
equitable order volume per pharmacist in order to decrease medication process bottlenecking and 
utilizing pharmacist capacity in the most efficient way. The post-model pharmacy queue 
distribution also associated each new queue with a certain disease state. There are no published 
articles that speak explicitly to the safety or efficiency of this type of pharmacist order 
verification structure and it should be noted that this study does not provide data that associates 
or correlates this model type to increased safety or efficiency. Pharmacy and nursing staff 
feedback supported pharmacy administration’s idea to orient pharmacists to  specific types of 
clinical patients.  It is also though that the consistency of pharmacists within a service line will 
be more accountable and able to seek continuing education and therefore provide better cognitive 
services within their respective patient population.  
The service-line technician model was associated with an 85% decrease in missing 
medications. This decrease is causative because the service-line technicians personally searched 
for each individual missing dose and were able to find 85% of the doses in their correct location. 
The high discrepancy between actual missing doses and reported missing doses is likely a 
product of a lack of knowledge of the different places that a medication may be located on a 
patient unit. A medication may be in the medication central drop area, within the ADM, or 
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within a refrigerator located on the unit. The service-line technician has a strong understanding 
of the locations of medications delivered to the floor and is therefore able to find missing 
medications with efficiency. Administrators within the pharmacy department are providing the 
pharmacy technician time to provide nursing education on the potential location of doses so that 
inappropriate missing dose requests are not processed. There is also an assumption being made 
by administration that the nurses will be more vigilant in looking for missing medications before 
reporting it to the pharmacy if they know that someone is going to search for it rather than 
simply reprocess through the pharmacy work flow to create a duplicate.  
The pharmacy department also created a new communication system that provides 
nursing with an option menu to speak to either the service-line technician or the central 
pharmacist. The service line technician is capable of taking missing medication, dose expedition, 
and basic ADM trouble-shooting questions. This results in the central pharmacist receiving only 
cognitive questions that need to be fielded by a pharmacist, rather than all phone calls that need 
to be triaged out to the correct person. A schematic of the pre and post model pharmacy phone 
triage is located in Figure 3.This system, if utilized appropriately will minimize interruptions to 
pharmacists assessing orders and therefore will allow for a more efficient and safe order 
verification process. This study did not assess phone call volume or appropriateness of phone 
call option selection.  
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Figure 3: Pre and post model phone triage process 
 
 Study Limitations 
This study only analyses surrogate markers for safety and efficiency. Therefore the 
conductors of the study cannot definitively state that these changes have resulted in increased 
efficiency for pharmacists, pharmacy order processing, or dispensing. The reorganization of the 
pharmacy order verification queues was based upon pre-model data and therefore theequity of 
the order distribution has not been confirmed with post-model order volume analysis.  
Future Steps 
Phone call volume comparisons may be valuable in the future as a marker of 
productivity/ marker of inefficiency. The manner in which phone calls are being triaged may also  
be assessed for appropriateness in the future. Administrators have also expressed interest in 
creating and distributing a nursing satisfaction survey. We have received anecdotal reports that 
the consistent contact between the nurses and the pharmacist/technician resource has improved 
their satisfaction with the medication distribution processes, but we do not have official data to 
speak to this affect.  
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CONCLUSIONS 
 
The redistribution of pharmacy queues may lead to a more equitable pharmacist order 
verification volume and therefore a more efficient utilization of pharmacist resources. The 
pharmacy automation optimization resulted in a significantly greater use of the RobotRx 
machine which is associated with more efficient and safer medication dispensing. The decreased 
frequency of ADM stockouts results signifies fewer pharmacy workflow failures post-model 
compared to pre-model.  
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APPENDIX: PHARMACY ORDER VERIFICATION QUEUES  
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Table 5: Pre-model pharmacist order verification queues – daylight shift
 
Units highlighted in red are Intensive Care Units (ICU) 
 
Pharmacist 
Queue 
Name
Unit Name Unit Description
Bed 
Number Order Volume 
3F Cardiac ICU (Valves, MI) 10
3E Cardiac Pavilion 18
CT10 CTICU (Heat/Lung Transplant, Surgery, 
ECMO) Long
10
CT11 CTICU (Heat/Lung Transplant, Surgery, 
ECMO) Acute
10
4D Cardiac Floor 18
5D Cardiac Floor 18
2D 
Overflow
Overflow SICU 6
SICU Surgical ICU 8
PACU PACU 4
10G Trauma Floor 24
11D Renal/Dialysis 10
Cath/RCLH Cath 10
MPUP Medical Producure Unit / GI lab 3
5SSU Overflow    10
ED ED 44
8D Neuro Floor/Step downs as well/Transitional 17
7F Medicine 13
8G Epilepsy/Neuro/ Neurovascular Step Down 24
6D Neuro Floor/Step downs as well/Transitional 18
5G Neuro Step Down 18
4F Neurovascular 10
5F Neurovascular 10
4G
Neurotrauma/OverflowNeurovascular and 
Trauma 10
9G Trauma Floor 24
6F Trauma ICU/GI Surgery/Neurovascular 
Overflow
10
6G Trauma ICU/ GI Surgery/Neurovascular 
Overflow
12
9D Cardiothroacic and Lung Transplant 17
7D Cardiothoracic Overflow 23
743F Neuro/medicine step down 4
12D Trauma Floor 23
R7SN Lung Transplant 20
R7SS Lung Transplant 16
9F (MICU) MICU 8
10F 
(MICU)
MICU 8
11F 
(MICU)
MICU 8
10C 
(MICU) MICU 8
10S (Med) Medicine 33
8MUH 
(ENT)
ENT Overflow 5
8N ENT 17
9N (Ortho) Orthopaedics 20
11S 
(RNHome)
Nursing Home 33
8W 
(SurgOnc) 11
12S Medicine
10W (Med) Medicine 34
10E (Med) Medicine
RHAB 
(Ortho)
Rehab 20
10N 
(SurgOnc) Head and Neck Surgical/GI Oncology 25
12N Solid Organ Transplant 24
11N Solid Organ Transplant 22
5E ICU Overflow unit/TICU/MICU 9
5W TICU 9
5S TICU 10
6NE 
(ClinRes)
Clinical Research Unit 5
7W 
(TranspOPt) Outpatient Transplant/Infusion Center 5
SDSM 
(Surg)
Same day surgery 10
7G Observation Unit 20
P
H
I
J 584
538
338
371
437
384
236
617L
M
N
O
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Table 6: Post-model pharmacist order verification queues – daylight shift 
 
Units highlighted in red are Intensive Care Units (ICU)  
Pharmacist Queue 
Name
Unit Name Description Bed Number Order Volume
12D Trauma Floor 23
9G Trauma Floor 24
7F Trauma Floor 13
8G Epilepsy/Neuro/ Neurovascular Step Down 24
6F Trauma ICU/GI Surgery/Neurovascular Overflow 10
6G Trauma ICU/ GI Surgery/Neurovascular Overflow 12
8D Neuro Floor/Step downs as well/Transitional 17
6D Neuro Floor/Step downs as well/Transitional 18
5G Neuro Step Down 18
4F Neurovascular 10
5F Neurovascular 10
4G Neurotrauma/OverflowNeurovascular and Trauma 10
3F Cardiac ICU (Valves, MI) 10
3E Cardiac Pavilion 18
CT10 CTICU 10
CT11 CTICU 10
4D Cardiac Floor 18
5D Cardiac Floor 18
11D Renal/Dialysis 10
Cath/RCLH Cath 10
MPUP Medical Producure Unit / GI lab 3
5SSU Overflow    10
ED ED 44
6NE Clinical Research Unit 5
7W Outpatient Transplant/Infusion Center 5
SDSM Same day surgery 10
8N Observation Unit 17
12N Solid Organ Transplant 24
11N Solid Organ Transplant 22
5E ICU Overflow unit/TICU/MICU 9
12S Medicine 33
5W TICU 9
5S TICU 10
7G Medicine 22
10D Lung Transplant 22
10G Lung Transplant 13
9D Cardiothroacic and Lung Transplant 17
7D Cardiothoracic Overflow 23
10W (Med) Medicine
10E (Med) Medicine
10S (Med) Medicine 33
8MUH ENT Overflow 5
8W ENT 11
9F MICU 8
10F MICU 8
11F MICU 8
10C MICU 8
2D Overflow SICU 6
SICU Surgical ICU 8
9N (Ortho) Orthopaedics 20
743F Neuro/medicine step down 4
RHAB Rehab 20
10N Head and Neck Surgical/GI Oncology 25
11S Nursing Home 33
PACU Post-Anesthesia Care Unit (PUH) 4
PACM Post-Anesthesia Care Unit (MUH) 4
NEUROLOGY
TRAUMA
426
468
384
402
465
494
MED SURG
MEDICINE
CT 
TRANSPLANT
34
464
ABDOMINAL 
TRANSPLANT
CARDIOLOGY
ANCILLARY 286
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Table 7: Post-model pharmacist order verification queues – evening shift 
 
Units highlighted in red are Intensive Care Units (ICU) 
  
Pharmaicst Queue 
Name
Units Description Bed Number Order Volume
8N Observation Unit 17
8D Neuro Floor/Step downs as well/Transitional 17
6D Neuro Floor/Step downs as well/Transitional 18
5F Neurovascular 10
4F Neurovascular 10
5G Neuro Step Down 18
4G Neurotrauma/OverflowNeurovascular and Trauma 10
CT10 CTICU (Heat/Lung Transplant, Surgery, ECMO) 10
CT11 CTICU (Heat/Lung Transplant, Surgery, ECMO) 10
4D Cardiac Floor 18
5D Cardiac Floor 18
3F Cardiac ICU (Valves, MI) 10
3E Cardiac Pavilion 18
7G Medicine 22
Cath/RCLH Cath 10
12N Solid Organ Transplant 24
11N Solid Organ Transplant 22
5W TICU 9
5E ICU Overflow unit/TICU/MICU 9
5S TICU 10
10D Lung Transplant 22
10G Lung Transplant 13
9D Cardiothroacic and Lung Transplant 17
7D Cardiothoracic Overflow 23
12S Medicine 33
10W (Med) Medicine
10E (Med) Medicine
10S (Med) Medicine 33
11F (MICU) MICU 8
10F (MICU) MICU 8
10C (MICU) MICU 8
9F (MICU) MICU 8
8MUH (ENT) ENT Overflow 5
8W ENT 11
11S (RNHome) Nursing Home 33
10N (SurgOnc) Head and Neck Surgical/GI Oncology 25
9N (Ortho) Orthopaedics 20
2D Overflow Overflow SICU 6
SICU Surgical ICU 8
RHAB (Ortho) Rehab 20
PACU Post-Anesthesia Care Unit (PUH) 4
PACM Post-Anesthesia Care Unit (MUH) 4
11D Renal/Dialysis 10
MPUP Medical Producure Unit / GI lab 3
7W (TranspOPt) Outpatient Transplant/Infusion Center 5
6NE (ClinRes) Clinical Research Unit 5
5SSU Overflow 0
SDSM (Surg) Same day surgery 10
743F Neuro/medicine step down 4
12D Trauma Floor 23
9G Trauma Floor 24
7F Trauma Floor 13
6F Trauma ICU/GI Surgery/Neurovascular Overflow 10
6G Trauma ICU/ GI Surgery/Neurovascular Overflow 12
8G Epilepsy/Neuro/ Neurovascular Step Down 24
ED ED 44
503
34
Transplant
Medicine
Med Surg
449
417
567
571
438
Neurology
Cardiology
Trauma
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Table 8: Post-model pharmacist order verification queues – night shift 
 
Units highlighted in red are Intensive Care Units (ICU) 
  
Pharmacist Queue 
Name Units Description Bed Number Order Volume
12D Trauma Floor 23
9G Trauma Floor 24
8G Epilepsy/Neuro/ Neurovascular Step Down 24
7F Trauma Floor 13
6F Trauma ICU/GI Surgery/Neurovascular Overflow 10
6G Trauma ICU/ GI Surgery/Neurovascular Overflow 12
8D Neuro Floor/Step downs as well/Transitional 17
6D Neuro Floor/Step downs as well/Transitional 18
5G Neuro Step Down 18
5F Neurovascular 10
4F Neurovascular 10
4G Neurotrauma/OverflowNeurovascular and Trauma 10
CT10 CTICU (Heat/Lung Transplant, Surgery, ECMO) Long 10
CT11 CTICU (Heat/Lung Transplant, Surgery, ECMO) Acut 10
4D Cardiac Floor 18
5D Cardiac Floor 18
3F Cardiac ICU (Valves, MI) 10
3E Cardiac Pavilion 18
11D Renal/Dialysis 10
8N Observation Unit 17
Cath/RCLH Cath 10
MPUP Medical Producure Unit / GI lab 3
ED ED 44
12N Solid Organ Transplant 24
11N Solid Organ Transplant 22
12S Medicine 33
5W TICU 9
5E ICU Overflow unit/TICU/MICU 9
5S TICU 10
10D Lung Transplant 22
10G Lung Transplant 13
9D Cardiothroacic and Lung Transplant 17
7D Cardiothoracic Overflow 23
7G Medicine 22
10W (Med) Medicine
10E (Med) Medicine
10S (Med) Medicine 33
11F (MICU) MICU 8
10F (MICU) MICU 8
10C (MICU) MICU 8
9F (MICU) MICU 8
8MUH (ENT) ENT Overflow 5
8W ENT 11
11S (RNHome) Nursing Home 33
10N (SurgOnc) Head and Neck Surgical/GI Oncology 25
9N (Ortho) Orthopaedics 20
7W (TranspOPt Outpatient Transplant/Infusion Center 5
743F Neuro/medicine step down 4
6NE (ClinRes) Clinical Research Unit 5
2D Overflow Overflow SICU 6
SICU Surgical ICU 8
RHAB (Ortho) Rehab 20
PACU PACU 4
PACM PACM 4
5SSU Overflow 0
SDSM (Surg) Same day surgery 10
Medicine
665
578
489
Trauma/Neuro/Cardio
Ancillary/Transplant
34
30 
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